Cytokinetics (NASDAQ: CYTK) is a South San Francisco-based drug company developing treatments for neurological conditions such as amyotrophic lateral sclerosis (Lou Gehrig’s Disease).
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars